TARM1
T-cell-interacting, activating receptor on myeloid cells protein 1
Also known as: TARM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- B6A8C7
- Gene
- TARM1
- Ensembl
- ENSG00000248385
- Chromosome
- 19
- Canonical length
- 271 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Enables immunoglobulin receptor binding activity. Involved in negative regulation of CD4-positive, alpha-beta T cell activation. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
271 residues, UniProt reviewed canonical sequence.
>B6A8C7|TARM1
1 MIPKLLSLLC FRLCVGQGDT RGDGSLPKPS LSAWPSSVVP ANSNVTLRCW TPARGVSFVL
61 RKGGIILESP KPLDSTEGAA EFHLNNLKVR NAGEYTCEYY RKASPHILSQ HSDVLLLLVT
121 GHLSKPFLRT YQRGTVTAGG RVTLQCQKRD QLFVPIMFAL LKAGTPSPIQ LQSPAGKEID
181 FSLVDVTAGD AGNYSCMYYQ TKSPFWASEP SDQLEILVTV PPGTTSSNYS LGNFVRLGLA
241 AVIVVIMGAF LVEAWYSRNV SPGESEAFKP ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against TARM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 6.6 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 6.6 nTPM
- spleen: 0.3 nTPM
- gallbladder: 0.1 nTPM
- retina: 0.1 nTPM
- testis: 0.1 nTPM
- adipose tissue: 0 nTPM
Single-cell type
- neutrophil progenitors: 3.7 nCPM
- distal convoluted tubule cells: 0.6 nCPM
- bergmann glia: 0.2 nCPM
- loop of henle epithelial cells: 0.2 nCPM
- microglia: 0.2 nCPM
- papillary tip epithelial cells: 0.2 nCPM
Immune cell
- basophil: 1.1 nTPM
- neutrophil: 0.7 nTPM
- classical monocyte: 0.5 nTPM
- intermediate monocyte: 0.3 nTPM
- total PBMC: 0.2 nTPM
- eosinophil: 0.1 nTPM
Brain region
- white matter: 2.5 nTPM
- choroid plexus: 2 nTPM
- cerebellum: 1.9 nTPM
- cerebral cortex: 1.7 nTPM
- pons: 1.7 nTPM
- amygdala: 1.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- immune response-regulating signaling pathway
- innate immune response
- negative regulation of CD4-positive, alpha-beta T cell activation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TARM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TARM1 as an antibody target. Whether an autoantibody or antibody against TARM1 could matter depends on whether native TARM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TARM1 is annotated at the cell surface, where native TARM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TARM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...